Exploring Psilocybin in Canadian Palliative Care: Unveiling History, Definition, and Legal Landscape

This is an insightful webinar as we delve into the world of psilocybin, examining its rich historical roots, precise definitions, and current gaps and limitations in palliative care. Our expert speakers will navigate the intricate legalities and regulations surrounding psilocybin use in the context of palliative patients, shedding light on its potential as a transformative therapeutic option.
Gain a comprehensive understanding of the past, present, and future of psilocybin in palliative care.
Host:
Dr. Jose Pereira, Pallium Canada
Presenters:
Dr. Ronald Shore
Dr. Jean Mathews
Guest panelists:
Geneviève Lalumière, BScN, RN MN
Dr. Kylea Potvin, MD
Dr. Lyle Galloway
This webinar is brought to you by the Palliative Care ECHO Project.
More about The Palliative Care ECHO Project: The Palliative Care ECHO Project is a 5-year national initiative to cultivate communities of practice and establish continuous professional development among health care providers across Canada who care for patients with life-limiting illness. Led by Pallium Canada and partners from across Canada, the Project will deliver a continuous learning journey for health care providers to build local capacity to provide a palliative care approach to patients and their families.
Stay connected to the Palliative Care ECHO Project: www.echopalliative.com.

[@siobhanskehan2654]

Great stuff.
I agree about the strong team approach needed. And I’d like to respectfully suggest that perhaps physicians aren’t best placed to be in the therapist role. Physicians will often need to UNlearn a lot of attitudes and habits that might undermine the process and hinder the openness required from the patient and their support team. Same for spiritual care providers to a lesser extent.
I’d like to see a new focus on non-religious spiritual (or existential) care and support, as well as perhaps incorporating the end of life doula role.
-cheaper than physicians
-can spend more time with patient
-groups are cheaper, yes, but lose some efficacy- one to one can be more effective, especially for complex cases
-more skilled at holding space and being present
-doulas can provide continuity of care when patients transferred between medical groups (eg from oncology to palliative care, and home to hospital etc
-doulas can also incorporate it with other end of life planning.
Looking forward to learning more and seeing how this all develops.